Sanofi Q3 EPADS $1.39 Misses $2.26 Estimate, Sales $13.02B Beat $12.56B Estimate
Portfolio Pulse from Benzinga Newsdesk
Sanofi (NASDAQ:SNY) reported Q3 earnings of $1.39 per share, missing the analyst consensus estimate of $2.26 by 38.5%. This is a 4.14% decrease from the same period last year. However, the company's quarterly sales of $13.02 billion beat the estimate of $12.56 billion by 3.68%, marking a 3.49% increase from last year.
October 27, 2023 | 7:52 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sanofi's Q3 earnings per share missed estimates by 38.5%, but sales exceeded expectations by 3.68%.
Sanofi's earnings miss could negatively impact investor sentiment and potentially lead to a short-term drop in the stock price. However, the sales beat might offset some of this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100